| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,008 |
2,580 |
$146K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
336 |
241 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
145 |
136 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
353 |
317 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
154 |
132 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
94 |
83 |
$7K |
| 87428 |
|
89 |
82 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
54 |
41 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
33 |
27 |
$3K |
| 87999 |
|
101 |
99 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15 |
13 |
$469.50 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
24 |
$377.95 |
| 90698 |
|
36 |
25 |
$230.40 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$192.84 |
| 96127 |
|
12 |
12 |
$175.20 |
| 90670 |
|
12 |
12 |
$76.80 |
| 3074F |
|
966 |
796 |
$0.00 |
| 1159F |
|
1,892 |
1,562 |
$0.00 |
| 1160F |
|
1,892 |
1,562 |
$0.00 |
| 3078F |
|
887 |
739 |
$0.00 |
| 3210F |
|
25 |
25 |
$0.00 |
| 99072 |
|
207 |
191 |
$0.00 |
| 1003F |
|
35 |
35 |
$0.00 |